The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis
Open accessAbstract
BACKGROUND: We conducted a systematic review of estimates of hepatitis C virus (HCV) vertical transmission risk to update current estimates published more than a decade ago. METHODS: PubMed and Embase were searched and 109 articles were included. Pooled estimates of risk were generated for children born to HCV antibody-positive and viremic women, aged ≥18 months, separately by maternal human immunodeficiency virus (HIV) coinfection. RESULTS: Meta-analysis of the risk of vertical HCV infection to children of HCV antibody-positive and RNA-positive women was 5.8% (95% confidence interval [CI], 4.2%-7.8%) for children of HIV-negative women and 10.8% (95% CI, 7.6%-15.2%) for children of HIV-positive women. The adjusted meta-regression model explained 51% of the between-study variation in the 25 included risk estimates. Maternal HIV coinfection was the most important determinant of vertical transmission risk (adjusted odds ratio, 2.56 [95% CI, 1.50-4.43]). Additional methodological (follow-up rate and definition of infection in children) and risk factors independently predicted HCV infection and need to be captured and reported by future studies of vertical transmission. Studies assessing the contribution of nonvertical exposures in early childhood to HCV prevalence among children at risk of vertical transmission are needed. CONCLUSIONS: More than 1 in every 20 children delivered by HCV chronically infected women are infected, highlighting that vertical transmission likely constitutes the primary transmission route among children. These updated estimates are a basis for decision making in prioritization of research into risk-reducing measures, and inform case management in clinical settings, especially for HIV-positive women in reproductive age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Transformations Related to the Angular and the Square Root
Freeman, M. F., & Tukey, J. W. (1950) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177729756 · Cited by 2,628
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
Epidemiology of hepatitis C virus infection
Alter, M. J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i17.2436 · Cited by 1,339
Cited by
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Ghany, M. G., Morgan, T. R., & Panel, A. H. C. G. (2020) · Hepatology · doi:10.1002/hep.31060 · Cited by 955
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Schillie, S., Wester, C., Osborne, M., Wesolowski, L., & Ryerson, A. B. (2020) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6902a1 · Cited by 558
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Cooke, G. S., Andrieux-Meyer, I., Applegate, T. L., Atun, R., Burry, J. R., Cheinquer, H., Dusheiko, G., Feld, J. J., Gore, C., Griswold, M. G., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30270-x · Cited by 535
Spearman, C. W., Dusheiko, G. M., Hellard, M., & Sonderup, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32320-7 · Cited by 404
Oxidative Stress, Testicular Inflammatory Pathways, and Male Reproduction
Dutta, S., Sengupta, P., Slama, P., & Roychoudhury, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810043 · Cited by 398
Role of oxidative stress, infection and inflammation in male infertility
Agarwal, A., Rana, M., Qiu, E., AlBunni, H., Bui, A. D., & Henkel, R. (2018) · Andrologia · doi:10.1111/and.13126 · Cited by 327
Bhattacharya, D., Aronsohn, A., Price, J., Lo Re, V., the American Association for the Study of Liver Diseases–Infectious Diseases Society of America HCV Guidance Panel, Heald, J., Demisashi, G., Durzy, E., Davis-Owino, A., & Tynes, S. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad319 · Cited by 296
Neu, N., Duchon, J., & Zachariah, P. (2015) · Clinics in Perinatology · doi:10.1016/j.clp.2014.11.001 · Cited by 289
Impact of COVID-19 on global HCV elimination efforts
Blach, S., Kondili, L. A., Aghemo, A., Cai, Z., Dugan, E., Estes, C., Gamkrelidze, I., Ma, S., Pawlotsky, J.-M., Razavi-Shearer, D., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.042 · Cited by 268
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
Safreed-Harmon, K., Thursz, M., Dillon, J., El-Sayed, M., Elsharkawy, A., Hatzakis, A., Jadoul, M., Prestileo, T., Razavi, H., Rockstroh, J., et al. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1666841 · Cited by 257
Hepatitis C virus infection among women giving birth—Tennessee and United States, 2009–2014.
Patrick, S. W., Bauer, A. M., Warren, M. D., Jones, T. F., & Wester, C. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6618a3 · Cited by 113
Hepatitis C virus screening among children exposed during pregnancy.
Chappell, C. A., Hillier, S. L., Crowe, D., Meyn, L. A., Bogen, D. L., & Krans, E. E. (2018) · PEDIATRICS · doi:10.1542/peds.2017-3273 · Cited by 112
Application of Dendrimers for the Treatment of Infectious Diseases
Mhlwatika, Z., & Aderibigbe, B. A. (2018) · Molecules · doi:10.3390/molecules23092205 · Cited by 97
Wu, S., Wang, J., Guo, Q., Lan, H., Sun, Y., Ren, M., Liu, Y., Wang, P., Wang, L., Su, R., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.03.002 · Cited by 56
Watts, T., Stockman, L., Martin, J., Guilfoyle, S., & Vergeront, J. M. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6642a3 · Cited by 49
Gowda, C., Kennedy, S., Glover, C., Prasad, M. R., Wang, L., & Honegger, J. R. (2018) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12481 · Cited by 15
Metadata
- Authors
- Benova, L., Mohamoud, Y. A., Calvert, C., & Abu-Raddad, L. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-13
- Volume
- 59
- Issue
- 6
- Pages
- 765-773
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2137401503
- Cited by
- 479
- References
- 34
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.